Socs3 is upregulated in obesity and inhibits leptin and insulin signaling (Palanivel et al., 2012), while its downregulation reduces hepatic lipid levels in obese Sprague–Dawley rats (Jiang et al., 2024). The gene discussed is INS; the disease is obesity disorder.